ArticleCytotherapy2012

Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.

Yerem Yeghiazarians et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.